Impact of renal function or folate status on altered plasma homocysteine levels in hypothyroidism

Endocrine Journal

Volumn 53, Issue 1, 2006, Pages 119-124

  Özmen, Bilgin ^a   Özmen, Dilek ^b   Parildar, Zuhal ^b   Mutaf, Işil ^b   Turgan, Nevbahar ^b   Bayindir, Oya ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Cystatin C; Folate status; Homocysteine; Hypothyroidism; Renal function

Indexed keywords

CREATININE; CYANOCOBALAMIN; CYSTATIN C; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHYROIDISM; KIDNEY FUNCTION; MALE; TURBIDIMETRY;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; CYSTATINS; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPOTHYROIDISM; KIDNEY; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; VITAMIN B 12;

EID: 33645007119     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.53.119     Document Type: Article

References (39)

1. Green R, Chong YY, Jacobson DW, Robinson K, Gupta M (1995) Serum homocysteine is high in hypothyroidism: A possible link with coronary artery disease. Irish J Med Sciences 164 (Suppl 15): 27-28.
2. Colleran KM, Romero LA, Upton DA, Burge M (2005) Methimazole-induced hypothyroidism paradoxically decreases homocysteine. Metab Clin Exper 54: 460-465.
3. Lindenbaum J, Klipstein FA (1964) Folic acid clearance and serum folate levels in patients with thyroid disease. J Clin Pathol 17: 666-670.
4. Nair CP, Viswanathan G, Noronha J (1994) Folate-mediated incorporation of ring-2 carbon of histidine into nucleic acids: influence of thyroid hormone. Metabolism 43: 1575-1578.
5. Kreisman SH, Hennessey JV (1999) Consistent reversible elevations of serum creatinine in severe hypothyroidism. Arch Intern Med 159: 79-82.
6. Capasso G, De Tommaso G, Pica A, Anastasio P, Capasso J, Kinne R, De Santo DG (1999) Effects of thyroid hormones on heart and kidney functions. Miner Electrolyte Metab 25: 56-64.
7. House JD, Brosnan ME, Brosnan JT (1997) Characterization of homocysteine metabolism in the rat kidney. Biochem J 328: 287-292.
8. Wollesen F, Brattström L, Refsum H, Ueland PM, Berglund L, Berne C (1999) Plasma tHcy and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 55: 1028-1035.
9. Randers E, Erlandsen EJ (1999) Serum cystatin C as an endogenous marker of the renal function - a review. Clin Chem Lab Med 37: 389-395.
10. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP (1995) Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47: 312-318.
11. Filler G, Witt I, Priem F, Ehrich JH, Jung K (1997) Are cystatin C and beta 2 -microglobulin better markers than serum creatinine for prediction of a normal GFR in pediatric subjects? Clin Chem 43: 1077-1078.
12. Mojiminiyi OA, Shayji IA, George S (1998) Serum cystatin could replace serum creatinine as an indicator of GFR in routine practice. Eur J Lab Med 6: 98-101.
13. Kyhse-Andersson J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, Grubb A (1994) Serum cystatin C, determined by a rapid automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for GFR. Clin Chem 40: 1921-1926.
14. Jayagopal V, Keevil BG, Atkin SL, Jennigs PE, Kilpatrick ES (2003) Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism. Clin Chem 49: 680-681.
15. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C (2003) Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63: 1944-1947.
16. Wiesli P, Schwegler B, Spinas GA, Schmid C (2003) Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 338: 87-90.
17. Hollander JG, Wulkan RW, Mantel MJ, Berghout A (2003) Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction? Clin Chem 49: 1558-1559.
18. Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, Lupi I, Pellegrini G, Bartalena L, Bogazzi F, Martino E (2005) Thyroid dysfunction differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 28: 346-349.
19. Turgan N, Boydak B, Habif S, Apakkan S, Özmen D, Mutaf I, Bayindir O (1999) Plasma homocysteine levels in acute coronary syndromes. Jpn Heart J 40: 729-736.
20. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
21. Lien EA, Nedrebo BG, Varhaug JE, Nygard O, Aakvaag A, Uelan P (2000) Plasma tHcy levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab 85: 1049-1053.
22. Nedrebo BG, Nygard O, Ueland PM, Lien EA (2001) Plasma tHcy in hyper- and hypothyroid patients before and during 12 months of treatment. Clin Chem 47: 1738-1741.
23. Barbe F, Klein M, Chango A, Fremont S, Gerard P, Weryha G, Gueant JL, Nicolas JP (2001) Homocysteine, folate, vitamin B12 and transcobalamins in patients undergoing successive hypo- and hyperthyroid states. J Clin Endocrinol Metab 86: 1845-1846.
24. Nedrebo BG, Ericsson UB, Nygard O, Refsum H, Ueland PM, Aakvaag A, Aanderud S, Lien EA (1998) Plasma tHcy in hyperthyroid and hypothyroid patients. Metabolism 47: 89-93.
25. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Müller B (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and double-blind, placebo-controlled trial. Atherosclerosis 166: 379-386.
26. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH (2001) Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 155: 195-200.
27. Hussein WJ, Green R, Jacobsen DW, Faiman C (1999) Normalization of hyperhomocysteinemia with Lthyroxine in hypothyroidism. Ann Intern Med 131: 348-351.
28. Luboshitzky R, Aviv A, Herer P, Lavie L (2002) Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12: 421-425.
29. Deicher R, Vierhapper H (2002) Homocysteine : A risk for cardiovascular disease in subclinical hypothyroidism. Thyroid 12: 733-736.
30. Diekman MJM, Van der Putt NM, Blom HJ, Tijssen JGP, Wiersinga WM (2001) Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol 54: 197-204.
31. Montenegro J, Gonzales O, Saracho R, Aguirre, R, Gonzales O, Martinez I (1996) Changes in renal function in primary hypothyroidism. Am J Kidney Dis 27: 195-198.
32. Polikar R, Burger AG, Scherrer U, Nicod P (1993) The thyroid and the heart. Circulation 87: 1435-1441.
33. Mussap M, Plebani M (2004) Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 41: 467-550.
34. Villabona C, Sahun M, Roca M, Mora J, Gomez N, Gomez J, Puchal R, Solder J (1999) Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci 318: 277-280.
35. rd edn. Harper Row, New York, 591-595 and 757-762.
36. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B (1994) Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 236: 631-641.
37. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J (1995) Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116: 59-62.
38. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H (1996) The effect of reduced glomerular filtration rate on plasma tHcy concentration. Scand J Clin Lab Invest 56: 41-46.
39. Norlund L, Grubb A, Fex G, Leksell H, Nilsson JE, Schenck H, Hultberg B (1998) The increase of plasma homocysteine with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 36: 175-178.